Abstract

Amongst the potential contribution of protein or peptide-display systems to study epitopes with relevant immunological features, the RAD display system stands out as a highly stable scaffold protein that allows the presentation of constrained target peptides. Here, we employed the RAD display system to present peptides derived from the SARS-CoV-2 Spike (S) protein as a tool to detect specific serum antibodies and to generate polyclonal antibodies capable of inhibiting SARS-CoV-2 infectivity in vitro. 44 linear S-derived peptides were genetically fused with the RAD scaffold (RAD-SCoV-epitopes) and screened for antigenicity with sera collected from COVID-19-infected patients. In a second step, selected RAD-SCoV-epitopes were used to immunize mice and generate antibodies. Phenotypic screening showed that some of these antibodies were able to recognize replicating viral particles in VERO CCL-81 and most notably seven of the RAD-SCoV-epitopes were able to induce antibodies that inhibited viral infection. Our findings highlight the RAD display system as an useful platform for the immunological characterization of peptides and a potentially valuable strategy for the design of antigens for peptide-based vaccines, for epitope-specific antibody mapping, and for the development of antibodies for diagnostic and therapeutic purposes.

Details

Title
SARS-CoV-2 Spike protein peptides displayed in the Pyrococcus furiosus RAD system preserve epitopes antigenicity, immunogenicity, and virus-neutralizing activity of antibodies
Author
Cioffi, Victor Bolsanelli 1   VIAFID ORCID Logo  ; de Castro-Amarante, Maria Fernanda 2   VIAFID ORCID Logo  ; Lulla, Aleksei 3   VIAFID ORCID Logo  ; Andreata-Santos, Robert 2   VIAFID ORCID Logo  ; Cruz, Mario Costa 4   VIAFID ORCID Logo  ; Moreno, Ana Carolina Ramos 5   VIAFID ORCID Logo  ; de Oliveira Silva, Mariângela 6   VIAFID ORCID Logo  ; de Miranda Peres, Bianca 6   VIAFID ORCID Logo  ; de Freitas Junior, Lucio Holanda Gondim 6   VIAFID ORCID Logo  ; Moraes, Carolina Borsoi 6   VIAFID ORCID Logo  ; Durigon, Edison Luiz 7   VIAFID ORCID Logo  ; Gordon, Nicola Coker 3   VIAFID ORCID Logo  ; Hyvönen, Marko 3   VIAFID ORCID Logo  ; de Souza Ferreira, Luís Carlos 8   VIAFID ORCID Logo  ; Balan, Andrea 1   VIAFID ORCID Logo 

 University of São Paulo, Laboratory of Applied Structural Biology, Department of Microbiology, Institute of Biomedical Sciences, São Paulo, Brazil (GRID:grid.11899.38) (ISNI:0000 0004 1937 0722) 
 University of São Paulo, Institute of Biomedical Sciences, Laboratory of Vaccine Development, Department of Microbiology, São Paulo, Brazil (GRID:grid.11899.38) (ISNI:0000 0004 1937 0722) 
 University of Cambridge, Department of Biochemistry, Cambridge, UK (GRID:grid.5335.0) (ISNI:0000 0001 2188 5934) 
 University of São Paulo, Av. Prof. Lineu Prestes, Core Facilities to Support Research (CEFAP), Institute of Biomedical Sciences, São Paulo, Brazil (GRID:grid.11899.38) (ISNI:0000 0004 1937 0722) 
 University of São Paulo, Institute of Biomedical Sciences, Laboratory of Vaccine Development, Department of Microbiology, São Paulo, Brazil (GRID:grid.11899.38) (ISNI:0000 0004 1937 0722); Butantan Institute, Vaccine Development Laboratory, São Paulo, Brazil (GRID:grid.418514.d) (ISNI:0000 0001 1702 8585) 
 University of São Paulo, Institute of Biomedical Sciences, Phenotypic Screening Platform, Department of Microbiology, São Paulo, Brazil (GRID:grid.11899.38) (ISNI:0000 0004 1937 0722) 
 University of São Paulo, Laboratory of Clinical and Molecular Virology, Institute of Biomedical Sciences, São Paulo, Brazil (GRID:grid.11899.38) (ISNI:0000 0004 1937 0722); Institut Pasteur de São Paulo, São Paulo, Brazil (GRID:grid.11899.38) 
 University of São Paulo, Institute of Biomedical Sciences, Laboratory of Vaccine Development, Department of Microbiology, São Paulo, Brazil (GRID:grid.11899.38) (ISNI:0000 0004 1937 0722); Institut Pasteur de São Paulo, São Paulo, Brazil (GRID:grid.11899.38) 
Pages
16821
Publication year
2023
Publication date
2023
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2873111187
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.